A computational method called scSurv, developed by researchers at Institute of Science Tokyo, links individual cells to patient outcomes using widely available bulk RNA sequencing data. The approach uses single-cell reference datasets together with patient survival data to infer the contributions of individual cells within complex tissues. The model identified cell populations associated with survival across several cancers, offering a way to uncover disease-driving cells and support the development of more targeted treatment strategies.